I have been critical of many governments’ handling of various aspects of the pandemic, but I don’t think ignoring Viraleze is a mistake. At the moment Viraleze is still in the no-clinical-evidence category, & no government or drug regulatory body should be recommending its use or spending money on it at this stage, just like they shouldn’t have stockpiled hydroxychloroquine or ivermectin.
I think the in vitro data on Viraleze is very promising, as is the pre-clinical study. But in the absence of randomised control trials in humans showing efficacy, it will never get beyond the chemist supplement-level of vague statements and low-level interest. At last year’s AGM I asked whether they were considering human trials and was disappointed with the answer of no.
Realistically Starpharma wouldn’t have the resources to run a trial large enough to test efficacy against Covid, so they’d need to partner with or sell it off to a major pharma to do this. I can’t see that happening either, so sadly I think Viraleze will stay as a novelty product, with its full potential never realised. And I say all that as a scientist and long-term investor, who is impressed with the science around all SPL’s products.
- Forums
- ASX - By Stock
- Ann: Quarterly Cashflow and Activities Report
I have been critical of many governments’ handling of various...
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
|
|||||
Last
9.5¢ |
Change
0.008(9.20%) |
Mkt cap ! $39.14M |
Open | High | Low | Value | Volume |
9.0¢ | 9.5¢ | 8.8¢ | $334.2K | 3.710M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 50354 | 9.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.5¢ | 22908 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 760087 | 0.089 |
2 | 147200 | 0.087 |
3 | 118061 | 0.086 |
3 | 220000 | 0.085 |
1 | 100000 | 0.084 |
Price($) | Vol. | No. |
---|---|---|
0.095 | 22908 | 2 |
0.096 | 5000 | 1 |
0.099 | 6837 | 1 |
0.100 | 71848 | 3 |
0.105 | 370000 | 2 |
Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online